Koyfin Home > Directory > Health Care > Amphastar Pharma > Total Revenue

Amphastar Pharma Total Revenue Chart (AMPH)

Amphastar Pharma annual/quarterly Total Revenue from 2014 to 2018. Revenue is the money that a business receives from its normal business activities, usually from the sale of goods and services to customers.
  • Amphastar Pharma Total Revenue for the quarter ending December 12, 2018 was $90m a 34.89% increase of 31m year over year
  • Amphastar Pharma Total Revenue for the last 12 months ending December 12, 2018 was $295m a 17.91% increase of 53m year over year
  • Amphastar Pharma Annual Total Revenue for 2018 was $295m a 18.49% increase of 54m from 2017
  • Amphastar Pharma Annual Total Revenue for 2017 was $240m a -6.24% decrease of -15m from 2016
  • Amphastar Pharma Annual Total Revenue for 2016 was $255m a 1.43% increase of 4m from 2015
Other Income Statement Metrics:
  • Amphastar Pharma EBITDA for the quarter ending December 12, 2018 was $6m a 196.48% increase of 11m year over year
  • Amphastar Pharma Net Income for the quarter ending December 12, 2018 was $2m a 488.11% increase of 9m year over year
View Chart On Koyfin

Quarterly AMPH Total Revenue Data

12/2018$90m
09/2018$76m
06/2018$71m
03/2018$58m
12/2017$60m
09/2017$58m
06/2017$65m
03/2017$57m
12/2016$64m
09/2016$64m

Annual AMPH Total Revenue Data

2018$295m
2017$240m
2016$255m
2015$252m
2014$210m
2013$230m